Bill Commons

MD HB 400

died on adjournment

Biotechnology Investment Incentive Tax Credit - Conversion to Grant Program

Maryland · 2026 Regular Session · lower

Quick answers

Did MD HB 400 pass?

No. MD HB 400 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-01-22): Hearing 2/12 at 1:00 p.m.

What is MD HB 400 about?

MD HB 400 is a bill in the 2026 Regular Session titled “Biotechnology Investment Incentive Tax Credit - Conversion to Grant Program”.

Who sponsors MD HB 400?

Chang is the primary sponsor of MD HB 400.

Introduced
—
Latest action
2026-01-22 — Hearing 2/12 at 1:00 p.m.
Bill type
bill
Last updated
—

Sponsors

  • Changprimary

Committees

Not provided by source.

Action timeline

  1. 2026-01-22

    First Reading Ways and Means

    referral-committee

  2. 2026-01-22

    Hearing 2/12 at 1:00 p.m.

Versions

  • First - Biotechnology Investment Incentive Tax Credit - Conversion to Grant ProgramCompare
  • (document, no version)Compare

Documents

Votes

Not provided by source.

Related bills

Official source

http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb0400?ys=2026RS

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:23:32.621655Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MD&identifier=HB 400. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.